Elastomer Infusion Pump Market Top Companies Analysis To growing at CAGR of 4.2% by 2026 | Palex Medical SA, Pfizer Inc.

UPDATE AVAILABLE ON-DEMAND

Elastomer infusion pumps are disposable medical devices that are used for administration of intravenous (IV) drugs such as antibiotics, analgesics, chemotherapy, and other medications. These devices use energy in an elastic membrane (inside the pump) to provide the force for drug delivery.

The global elastomer infusion pump market size was valued at $534 million in 2018, and is projected to reach $745 million by 2026, growing at a CAGR of 4.2% from 2019 to 2026.

Download Free Report Sample @ https://www.alliedmarketresearch.com/request-sample/6323

COVID-19 scenario-

1) Due to the global pandemic all over the world, the medical devices manufacturers are majorly focusing on essential medical devices production including ventilators and diagnostics.

2) However, due to the precautionary measures taken by governments in various regions, the supply chain has been hampered. Which may result in shortage of devices in certain locations.

3) Food and Drugs Administration (FDA), on the other hand, shared a COVID-19 guidance with medical device manufacturers to notify the agency about changes that could affect availability of their products.

In addition, it provides advantages over conventional electronic pumps in features such as portability, feasibility, and lesser scope for human errors. However, pump failure can have a significant impact on patient safety, making it required for pumps to be operated by a trained professional. The two major types of elastomer infusion pumps are continuous rate pumps, and variable rate pumps.

The major factors that boost the growth of the global elastomer infusion pump market are increase in demand for elastomer infusion pumps, rise in prevalence of chronic diseases, increase in number of surgeries, surge in preference for long-term home healthcare, technological development of novel elastomeric infusion pumps, rise in burden on hospitals to reduce healthcare costs, and rise in availability of elastomer infusion pumps. In addition, factors such as longer storage and stability of the drug, reduced cost, portability and reduce risk of introduction of an infection, are expected to further influence the growth of the elastomer infusion pumps market. However, low income and lack of proper medical attention in the developing countries hamper the growth of the elastomer infusion pump market.

Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/6323

By application, the global elastomer infusion pump market is segmented into pain management, infection management, chemotherapy, and others. Pain management is the major shareholder in the global elastomer infusion pump market owing to rise in number of orthopedic procedures & surgeries, increase in use of elastomer infusion pumps for administration of analgesic drugs, and less complications are observed as compared to opioids dosage are the key drivers of the pain management segment.

Based on product, the elastomer infusion pump market is categorized into continuous rate pumps, and variable rate pumps. Presently, continuous rate pumps dominates the global market, and is anticipated to continue this trend during the forecast period. The key factors that drive the elastomer infusion pump market growth are rise in demand for continuous rate elastomeric pumps, wide usage of continuous rate pumps in chronic disease treatment, increase in adoption of elastomer infusion pump for post-operative pain management, and increase in application in cancer treatment are majorly driving the growth of this segment.

In 2018, North America accounted for the major share in the elastomer infusion pump market, and is expected to continue this trend during the forecast period, owing to availability of well-developed infrastructure, higher number of R&D activities with large presence of key players, rise in demand for elastomers infusion pumps, surge in prevalence of chronic diseases, and increase in non-government & government initiatives to promote healthcare. However, Asia-Pacific is expected to register the highest growth in the future owing to improvement in healthcare infrastructure, and technological advancements in the field of healthcare, and the developing R&D sector.

Access Full Report @ https://www.alliedmarketresearch.com/elastomer-infusion-pump-market-A05958

The Major Key Players Are:

B. Braun Melsungen Ag, Baxter International Inc., Halyard Health, Heka Healthcare, Nipro Medical Corporation (Nipro Medical Europe NV), Palex Medical SA, Pfizer Inc. (Hospira Inc.), Pfm Medical Ag, and PROMECON GmbH.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.